Roch  Doliveux net worth and biography

Roch Doliveux Biography and Net Worth

Director of Stryker
Dr. Roch Doliveux serves as Independent Director of the Company. He is a Chairman of the Board, Pierre Fabre SA, a global dermocosmetics and healthcare company. Chairman of GLG Institute, a community of senior executives for experience sharing and learning. Director of UCB, a global biopharmaceutical company, where he was Chief Executive Officer for 10 years. He is also Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium and of the Caring Entrepreneurship Fund, a philanthropic organization to help entrepreneurs start their own businesses in healthcare. Dr. Doliveux has extensive experience in life science and healthcare companies, including research, development, regulatory, medical, marketing, market access, sales and M&A, as well as strategic and organizational change management. His exposure to business in many geographies and cultures is very valuable as Stryker seeks to expand its global presence.

What is Roch Doliveux's net worth?

The estimated net worth of Roch Doliveux is at least $8.52 million as of July 31st, 2020. Dr. Doliveux owns 22,070 shares of Stryker stock worth more than $8,519,682 as of November 21st. This net worth evaluation does not reflect any other assets that Dr. Doliveux may own. Learn More about Roch Doliveux's net worth.

How do I contact Roch Doliveux?

The corporate mailing address for Dr. Doliveux and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Roch Doliveux's contact information.

Has Roch Doliveux been buying or selling shares of Stryker?

Roch Doliveux has not been actively trading shares of Stryker during the past quarter. Most recently, on Friday, July 31st, Roch Doliveux bought 53 shares of Stryker stock. The stock was acquired at an average cost of $191.94 per share, with a total value of $10,172.82. Following the completion of the transaction, the director now directly owns 22,070 shares of the company's stock, valued at $4,236,115.80. Learn More on Roch Doliveux's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 490,063 shares worth more than $165,955,919.20. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.9% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Roch Doliveux Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2020Buy53$191.94$10,172.8222,070View SEC Filing Icon  
4/30/2020Buy51$190.09$9,694.5921,080View SEC Filing Icon  
1/31/2020Buy45$216.67$9,750.1520,912View SEC Filing Icon  
10/31/2019Buy40$216.77$8,670.8020,867View SEC Filing Icon  
7/31/2019Buy41$212.84$8,726.44132,070View SEC Filing Icon  
4/30/2019Buy43$188.77$8,117.1119,738View SEC Filing Icon  
1/31/2019Buy46$177.26$8,153.96View SEC Filing Icon  
10/31/2018Buy45$163.39$7,352.5519,649View SEC Filing Icon  
7/31/2018Buy44$165.32$7,274.0819,604View SEC Filing Icon  
4/30/2018Buy43$171.27$7,364.6119,560View SEC Filing Icon  
1/31/2018Buy43$164.94$7,092.4218,797View SEC Filing Icon  
10/31/2017Buy41$155.94$6,393.5418,754View SEC Filing Icon  
8/1/2017Buy43$144.93$6,231.9918,713View SEC Filing Icon  
4/28/2017Buy46$135.66$6,240.3618,670View SEC Filing Icon  
1/31/2017Buy41$123.12$5,047.9217,709View SEC Filing Icon  
See Full Table

Roch Doliveux Buying and Selling Activity at Stryker

This chart shows Roch Doliveux's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $386.03
Low: $384.60
High: $387.19

50 Day Range

MA: $365.46
Low: $345.14
High: $390.08

2 Week Range

Now: $386.03
Low: $285.79
High: $398.20

Volume

23,673 shs

Average Volume

1,264,979 shs

Market Capitalization

$147.16 billion

P/E Ratio

41.38

Dividend Yield

0.82%

Beta

0.91